OM:BIOA BBiotechs
How Investors Are Reacting To BioArctic (OM:BIOA B) Third-Quarter Royalties Surging 68% Year-on-Year
BioArctic AB recently reported its third quarter 2025 sales results, revealing total sales of ¥18 billion and resulting royalty income of SEK117.2 million, which is approximately 68% higher than the royalty earned in the same quarter of 2024.
This sharp royalty increase underscores powerful commercial momentum for the company’s partnered Alzheimer’s therapy and highlights a significant year-on-year revenue boost.
We'll explore how BioArctic's surging third-quarter royalties could reshape...